Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2024-08-07

Clinical Trial Update: tDCS to Treat Subacute Aphasia [NA]

View source ↗

Summary

The clinical trial studying transcranial direct current stimulation for subacute aphasia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Pennsylvania | Conditions: Aphasia, Stroke, Acute | NA | Status: WITHDRAWN